Humoral immune response after COVID-19 infection or BNT162b2 vaccine among older adults: evolution over time and protective thresholds노년층에서 COVID-19 감염 또는 BNT162b2 백신 후 체액성 면역 반응: 시간 경과에 따른 진화 및 보호 역치Article Published on 2022-06-012022-09-12 Journal: GeroScience [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] age Anti-RBD IgG Antibody titer BNT162b2 vaccine COVID-19 COVID-19 infection decrease Dynamics Evolution first vaccination immune response Infection injection IQR Kinetics less maintain natural infection Older Patient patients with SARS-CoV-2 Protective SARS-CoV-2 serological test serology significantly higher Support symptom onset the median the SARS-CoV-2 the vaccine three groups threshold vaccination Vaccine vaccine group [DOI] 10.1007/s11357-022-00546-y PMC 바로가기 [Article Type] Article
Information From Same-Race/Ethnicity Experts Online Does Not Increase Vaccine Interest or Intention to VaccinateRandomized Controlled Trial Published on 2022-06-012022-10-04 Journal: The Milbank quarterly [Category] 임상, [키워드] affected Analysis Asian assigned black conducted Consequences control condition coronavirus COVID-19 COVID-19 pandemic COVID-19 vaccine effective Efficacy Ethnic groups Ethnicity Evidence experiment expert expert messaging had no identity increase information Intention interest mass vaccination pandemic participant Point Policy Population populations produced provide public health race Racial Randomly the United State The United States the vaccine vaccinate vaccination vaccination intentions vaccination rates Vaccine Vaccine hesitancy [DOI] 10.1111/1468-0009.12561 PMC 바로가기 [Article Type] Randomized Controlled Trial
A rare case of COVID-19 vaccine-induced myopericarditis in a young adultCase report Published on 2022-06-012022-10-05 Journal: Radiology Case Reports [Category] 바이오마커, [키워드] administration adverse effect Care COVID-19 COVID-19 pandemic Ejection fraction General population highlight induce manifestation mRNA mRNA vaccine myocarditis Myopericarditis pericardial effusion Pericarditis physical reduced risk factor second dose Shortness of breath temperature the vaccine vaccination Vaccine ventricular ventricular dysfunction [DOI] 10.1016/j.radcr.2022.03.039 [Article Type] Case report
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial영국에서 ChAdOx1 nCov-19 또는 BNT162b2 2회 접종 후 3차 추가 접종으로 7가지 COVID-19 백신을 투여한 후 면역원성의 지속성: COV-BOOST 시험의 3개월 분석Clinical Trial Published on 2022-06-012022-09-11 Journal: The Journal of Infection [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 임상, 진단, [키워드] Ad26 Ad26.COV2.S adenoviral vector adenoviral vector vaccine Analysis anti-Spike IgG antibody AstraZeneca BNT BNT162b2 booster booster dose cellular response Cellular responses ChAd ChAdOx1 ChAdOx1 nCoV-19 Concentration conducted COV-BOOST COVID-19 COVID-19 vaccine Critical death dose doses evaluate Fractional dose geometric mean geometric mean concentration geometric mean ratio GMR GMRs Heterologous boost highest Homologous boost humoral Humoral response immune response immune responses immunogenicity initial janssen long-lasting maintenance median age mRNA mRNA vaccine mRNA vaccines multicentre naïve no significant difference Oxford-AstraZeneca participant persistence Pfizer-BioNTech Phase 2 phase 2 trial randomised referred to response responses SARS-CoV-2 Seven severe disease significant difference significantly higher the vaccine third dose Transmission Trial Vaccine Vaccines variants of concern while [DOI] 10.1016/j.jinf.2022.04.018 PMC 바로가기 [Article Type] Clinical Trial
A conserved subunit vaccine designed against SARS-CoV-2 variants showed evidence in neutralizing the virusSARS-CoV-2 변이체에 대해 설계된 보존 소단위 백신은 바이러스를 중화하는 증거를 보여주었습니다Article Published on 2022-06-012022-09-11 Journal: Applied Microbiology and Biotechnology [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] addition affinity analyzed antibody approach B-cell response conserved coronavirus coronavirus disease country Coverage COVID-19 Cytopathic effect docking domain Efficiency elicit envelope envelope protein epitope Epitope-based vaccine Epitopes Evidence FIVE genomes glycoprotein highest IgG immunogenic immunoinformatics IMPROVE induce linker lung tissue membrane membrane glycoprotein MHC MHC class MHC class I MHC class II mice molecular molecular docking Multi-epitope vaccine Mutation neutralize Neutralizing Neutralizing antibodies neutralizing antibody novel Novel coronavirus omicron outbreak pandemic peptide peptides Proteins recognize reported required S1 and S2 S2 domain SARS-CoV-2 SARS-CoV-2 genomes SARS-CoV-2 variant SARS-CoV-2 variants selected sequence sequences spike Spike surface glycoprotein, Immunogenic, Neutralizing antibody. Spread step subunit Subunit vaccine Surface glycoprotein surface protein surface proteins T-cell T-cell epitope T-cell epitopes the vaccine Vaccine vaccine construct variant variants variants of SARS-CoV-2 Vero Cell viral surface virus virus replication wild type wild-type virus [DOI] 10.1007/s00253-022-11988-x PMC 바로가기 [Article Type] Article
Neuromuscular complications after COVID-19 vaccination: a series of eight patients코로나19 예방접종 후 신경근 합병증: 8명의 환자 연속Case Reports Published on 2022-06-012022-09-11 Journal: Acta neurologica Belgica [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 association brachial can not Care Case series case sery causal relationship chronic inflammatory demyelinating polyneuropathy CIDP classical collected Complication Coronavirus-2 COVID-19 COVID-19 vaccination COVID-19 vaccine disorder eight Epidemiological study etiology Guillain-Barré Guillain-barrè syndrome Immune-mediated include Infection Inflammatory limbs neurologic Neuromuscular one patient paresthesia Patient phenotype Phenotypes Polyneuropathy receiving reported SARS-CoV-2 second dose secondary care syndrome the vaccine two patients vaccination Vaccine variant weakness with COVID-19 [DOI] 10.1007/s13760-022-01941-0 PMC 바로가기 [Article Type] Case Reports
Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events장내 미생물 조성은 SARS-CoV-2 백신 면역원성 및 부작용과 관련이 있습니다.Observational Study Published on 2022-06-012022-09-12 Journal: Gut [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] adverse event Anti-inflammatory antibody association Bacteria Bacterial baseline Bifidobacterium BNT162b2 BNT162b2 vaccine carbohydrate collected complement conducted CoronaVac COVID-19 COVID-19 vaccinee COVID-19 vaccines Effectiveness enteric bacterial microflora flagella Gut gut microbiota gut microbiota composition high neutralising antibody Host immune response IgG ELISA immune response Inactivated vaccine individual Intervention Linear Discriminant Analysis marker metabolism metagenomic sequencing Microbiome microbiota modulating mRNA vaccine pathway performed positive correlation Prevotella recipient reduced SARS-CoV-2 SARS-CoV-2 vaccine second dose significantly lower Sinovac spike receptor-binding domain Stool subject the vaccine vaccination Vaccine vaccinee vaccinees Virus neutralisation were measured [DOI] 10.1136/gutjnl-2021-326563 PMC 바로가기 [Article Type] Observational Study
Infrastructural capital in the Israeli vaccination campaign against COVID-19Research article Published on 2022-06-012022-10-05 Journal: Social science & medicine (1982) [Category] 유전자 메커니즘, [키워드] acquisition Biocapitalism country Coverage COVID COVID-19 dose Drawing explain Government implication Infrastructural capital Israel medical records Pfizer Pharma question resource secure State-power the vaccine vaccinate vaccination vaccination rates Vaccine [DOI] 10.1016/j.socscimed.2022.115022 [Article Type] Research article
Data on immunogenicity and reactogenicity to COVID-19 vaccination among patients receiving maintenance dialysisData article Published on 2022-06-012022-10-05 Journal: Sensors (Basel, Switzerland) [Category] 변종, [키워드] acute respiratory syndrome assays cellular Cellular immune response Complete coronavirus coronavirus disease COVID-19 COVID-19 vaccination dialysis dose Effectiveness ELISPOT exclusion General population Hemodialysis homologous humoral immune response immune response Immunity immunoassay immunoglobulins increased risk interferon-γ Microparticle morbidity and mortality Patient Peritoneal dialysis produced reactogenicity receiving regimen SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine single dose T cells tested the vaccine trials vaccination [DOI] 10.1016/j.dib.2022.108271 [Article Type] Data article
Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccinesArticle Published on 2022-06-012022-10-05 Journal: Allergology international : official journal of th [Category] 진단, 치료기술, [키워드] allergic allergic reaction allergy antibodies Antigen applied BNT162b2 cause component control group controls COVID-19 COVID-19 mRNA Vaccination COVID-19 mRNA vaccine COVID-19 mRNA vaccines diagnosing enzyme-linked immunosorbent Evidence FIVE healthy control hypersensitivity IgE IgG Immunoglobulin Intradermal test mechanism Moderna mRNA vaccine mRNA-1273 Patient PEG-specific IgE PEG-specific IgG Pfizer-BioNTech Polyethylene glycol Polysorbate recruited Result Skin test Symptom the vaccine vaccination Vaccine Vaccines were measured [DOI] 10.1016/j.alit.2022.05.007 [Article Type] Article